BRCA1 mutation + TP53 mutation
|
Prostate Cancer
|
BRCA1 mutation + TP53 mutation
|
Prostate Cancer
|
rucaparib Sensitive: C3 – Early Trials
|
rucaparib Sensitive: C3 – Early Trials
|
BRCA1 mutation + TP53 mutation
|
Breast Cancer
|
BRCA1 mutation + TP53 mutation
|
Breast Cancer
|
AZD1775 + SRA737 Sensitive: D – Preclinical
|
AZD1775 + SRA737 Sensitive: D – Preclinical
|